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GM1 ganglioside tritium-labeled at C-3 of sphingosine has been administered to rat cerebellar granule cells. Tritiated polysialylated gangliosides 
were observed in the cytosol of the cells, where they resulted in a higher amount after a short period of chase. This, together with the data showing 
an increase of the tritiated polysialylated gangliosides in the total particulate fraction in parallel to the prolonging of the chase period, suggests 
that cytosolic gangliosides could be a way of transporting neosynthesized gangliosides from the GoIgi apparatus to the plasma membranes. 
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1. INTRODUCTION 
Gangliosides are normal components of the 
vertebrate cells and are particularly abundant in the 
neurons [I]. Although the main site of ganglioside 
deposition is the plasma membrane, small amounts of 
gangliosides occur as soluble complexes with proteins in 
the brain of different animals as well as in other tissues 
and cells in culture [2-81. 
In experiments where radioactive galactose [5] or N- 
acetylmannosamine [6] were used as precursors for 
ganglioside biosynthesis, the specific radioactivity was 
2-3 times higher for cytosolic than for membrane- 
bound gangliosides particularly at the initial stages of 
precursor involvement. This suggested the hypothesis 
that cytosolic gangliosides are involved with the in- 
tracellular traffic of gangliosides linked to their 
metabolic processing. 
Rat cerebellar granule cells were shown [9] to take up 
administered gangliosides. In the present work we fed 
cerebellar granule cells in culture with GM1 ganglioside 
tritium-labeled at C-3 of long chain bases and observed 
the occurrence of tritiated polysialylated gangliosides in 
the cell cytosol. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Commercial chemicals were the purest available; common solvents 
were distilled and water was doubly distilled in a glass apparatus. 
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En3Hance spray was from New England Nuclear. X-Omat SO-282 
films were from Kodak. All the solutions for cell cultures and washing 
were from Flow Laboratories. GM1 ganglioside was extracted from 
calf brain [lo], purified over 99% and characterized [I 11. GM1 
ganglioside was tritium-labeled at position 3 of long chain bases 
according to the dichlorodicyanobenzoquinone/[3H]sodium 
borohydride procedure [12]. The used molecular species that contain- 
ed C-18 sphingosine with the erythro configuration was prepared by 
reversed phase HPLC purification [13]. Standards GM3, GM2, 
GDla, GDlb, GTlb were prepared from calf brain and 0-Ac-GTlb 
from rat brain [l I]. 
2.2. Cell cultures and cell culture treatments 
Granule cells, obtained from the cerebellum of 8-day-old rats, were 
prepared and cultured as already described [14]. Treatment with 
radiolabeled ganglioside was carried out on day 7 in culture. To this 
purpose, dishes were washed twice with prewarmed supplemented 
basal modified Eagle’s medium without fetal calf serum (FCS) and 
then incubated in the same medium (2 ml/dish) containing 15 x IO6 
dpm of tritiated ganglioside. After 15 h, the medium containing the 
radioactive material was discarded, and the cells were washed for 30 
min with supplemented basal modified Eagle’s medium containing 
10% FCS to eliminate the pericellular, loosely bound micelles of 
gangliosides. During the 15-h incubation in the absence of FCS no 
visible alterations in cell morphology were observed. Chase was done 
with 5 ml of 10% FCS-containing medium for 4 or 24 h. At the end 
the medium was carefully removed, and the cells were rinsed twice 
with 0.32 M sucrose containing 0.1 mM bisodium EDTA and 1 mM 
potassium phosphate buffer, pH 7, scraped off the plates, and cen- 
trifuged. Pelleted cells were homogenized at 4°C by gentle 50-fold up- 
and-down pipetting in 200 pl buffered 0.32 M sucrose solution, and 
the suspension was centrifuged at 105 000 x g for 1 h at 4°C. The up- 
per third of the supernatant (cytosolic fraction) was accurately 
siphoned, the remaining supernatant being disregarded. This precau- 
tion was adopted in order to avoid any inadvertent withdrawal of par- 
ticulated fines floating above the pellet. The collected supernatant 
was dialysed, frozen, and lyophilized. The 105 OOOxg pellet (total 
particulate fraction) and the lyophilized supernatant were suspended 
(0.1 mg protein/ml) in 0.01 N potassium phosphate buffer, pH 7, and 
gangliosides were extracted and purified from the other lipids [lo]. 
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Table I 
Distribution of cell radioactive gangliosides, after 15 h pulse-administration of tritiated long chain bases containing GM1 to rat cerebellar granule 
cells in culture 
Cell fraction Chase (hr) GTlb 0-Ac-GTlb GDlb GDla GM1 GM2 GM3 
Percent 
cyiosol 4 tra 0.65 0.76 0.90 90.49 5.60 1.60 
cytosol 24 0.33 0.51 0.75 91.25 5.55 1.61 
particulate 4 0.45 0.40 0.35 0.17 83.45 10.33 4.25 
particulate 24 1.11 1.02 0.80 1.43 81.10 10.31 3.15 
dum x 10-3/mg orotein 
cytosol 4 tra 1.80 2.11 2.50 277.80 
cytosol 24 0.67 1.03 1.51 201.70 
particulate 4 3.56 3.17 2.27 6.10 192.20 
particulate 24 8.00 1.35 6.35 10.31 721.10 
Data are means of 4 experiments; SD for GM1 value <3%, for the other gangliosides k 10%. ‘tr = traces 
15.56 4.45 
11.19 3.25 
81.81 33.66 
74.33 27.04 
2.3. Anal_vtical procedures 
Total ganglioside radioactivity was determined by liquid scintilla- 
tion counting. 
Gangliosides were separated by TLC using 10 cm long HPTLC 
plates developed at room temperature, the solvent system 
chloroform/methanol/0.2% aqueous CaClz (50:42: 11 v/v), reaching 
the top edge of the plate. Gangliosides were identified by 
chromatographic omparison with standard gangliosides. Radioac- 
tive spots were quantified by radiochromatographic s anning of the 
plate using a Berthold TLC linear analyzer LB282 equipped with an 
Apple 11 data system. Protein content was determined in solubilized 
pellet and cytosolic fraction [15,16], bovine serum albumin being used 
as the reference standard. 
3. RESULTS AND DISCUSSION 
After 15 h pulse and 4 h chase, 95-96% of the total 
ganglioside radioactivity was in the total particulate 
fraction and 4-5’70 in the cytosol. Prolonging the chase 
up to 24 h, the soluble radioactivity remained constant, 
this reflecting the long period of pulse. Six gangliosides 
different from GM1 were found in radioactive form 
and identified, in both total particulate fraction and 
cytosol: GM3, GM2, GDla, GDlb, GTlb and O-Ac- 
GTlb. The ganglioside distribution, in the particulate 
and cytosol fractions at two us’ed periods of chase, is 
reported in Table I. 
GM3 and GM2 are present at trace level in the 
granule cells [9] and their high percent value is mainly 
representative of the GM1 catabolic processing, and 
their presence in the cytosol is probably due to a partial 
lysis of the lysosomes wih release of its components. 
GDla, GDlb, GTlb and 0-Ac-GTlb derive by 
biosynthetic reactions. The amount of gangliosides 
GDla, GDlb, GTlb and 0-Ac-GTlb prolonging the 
chase, increased in the total particulate fraction, this in 
agreement with previous data [9], and decreased in the 
cytosol. These data would indicate a flow of soluble 
gangliosides, that according to previous results [3,8] 
should be a flow of ganglioside/protein complexes, 
from the biosynthetic ompartment o the plasma mem- 
brane through the cell cytosol. This flow is high when 
the availability of radioactive substrates for ganglioside 
biosynthesis is high, that is when the amount of ex- 
ogenously administered ganglioside is high such as at a 
short time of chase after a long pulse. Far from the 
pulse, the administered ganglioside is to a large extent 
catabolized, the amount of intermediate for ganglioside 
biosynthesis reduced and in parallel the amount of solu- 
ble polysialylated gangliosides is decreased. As a conse- 
quence of these events prolonging the chase time the 
amount of neosynthesized gangliosides increases at the 
membrane level. According to the above interpretation, 
cytosolic gangliosides would be representative, at least 
in part, of a way to transport neosynthesized 
gangliosides from the Golgi apparatus to the plasma 
membranes. 
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